Literature DB >> 27889779

Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway.

Lijuan Ding1, Lijuan Ding1, Shudong Wang, Shudong Wang, Weiyao Wang, Weiyao Wang, Peng Lv, Peng Lv, Donghai Zhao, Donghai Zhao, Feier Chen, Feier Chen, Tianjiao Meng, Tianjiao Meng, Lihua Dong, Lihua Dong, Ling Qi, Ling Qi.   

Abstract

OBJECTIVE: To test the effects of Tanshinone IIA (Tan IIA) on cell viability, cycle, apoptosis, and autophagy of human glioma cell U251 by regulating phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signal pathway.
METHODS: Tan IIA and PI3K agonist (740 Y-P) were used to treat glioma cells U251. MTT assay was used to assess cell viability and flow cytometry was used to detect cell apoptosis and cell cycle. The expressions of apoptosis-related proteins (Bcl-2 and Bax), autophagy-related proteins (LC3B and Beclin 1) and PI3K/Akt/mTOR signal pathway-associated proteins (p-PI3K, p-Akt and p-mTOR) were evaluated by Western blotting.
RESULTS: Tan IIA decreased the expression of p-PI3K and p-Akt proteins, inhibited cell viability and promoted apoptosis. Meanwhile, the expression of Bax increased, while the expression of Bcl-2 decreased. In addition, Tan IIA promoted autophagy in U251 glioma cells and raised the expression of LC3B and Beclin 1. However, 740 Y-P played a reversed role of Tan IIA in cell viability, cycle, apoptosis, and autophagy of U251 cells.
CONCLUSION: Tan IIA could suppress the viability of U251 cells and induce cell apoptosis and autophagy, which might be related to the inhibition of the PI3K/Akt/mTOR signal pathway.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27889779     DOI: 10.1159/000452340

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  15 in total

Review 1.  Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.

Authors:  Gulten Tuncel; Rasime Kalkan
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

Review 2.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

3.  Tanshinone IIA Protects Hippocampal Neuronal Cells from Reactive Oxygen Species Through Changes in Autophagy and Activation of Phosphatidylinositol 3-Kinase, Protein Kinas B, and Mechanistic Target of Rapamycin Pathways.

Authors:  Yingchun Zhu; Qiqiang Tang; Guopin Wang; Ruodong Han
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

4.  Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.

Authors:  Sung-Ying Huang; Shu-Fang Chang; Kuan-Fu Liao; Sheng-Chun Chiu
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

5.  Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells.

Authors:  Zong-Yang Li; Guo-Dong Huang; Lei Chen; Ce Zhang; Bao-Dong Chen; Qing-Zhong Li; Xiang Wang; Xie-Jun Zhang; Wei-Ping Li
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

6.  Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.

Authors:  Xiao-Zhong Liao; Ying Gao; Sheng Huang; Zhuang-Zhong Chen; Ling-Ling Sun; Jia-Hui Liu; Han-Rui Chen; Ling Yu; Jia-Xing Zhang; Li-Zhu Lin
Journal:  Phytother Res       Date:  2019-07-03       Impact factor: 5.878

7.  Tanshinone IIA attenuates Aβ-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-κB pathway in SH-SY5Y cells.

Authors:  Lijiao Geng; Wei Liu; Yong Chen
Journal:  J Biol Res (Thessalon)       Date:  2019-11-12       Impact factor: 1.889

8.  Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway.

Authors:  Lifang Ma; Hongyuan Jiang; Xin Xu; Congcong Zhang; Yongjie Niu; Zhixian Wang; Yuquan Tao; Yan Li; Feng Cai; Xiao Zhang; Xinghe Wang; Yongchun Yu
Journal:  Aging (Albany NY)       Date:  2019-11-11       Impact factor: 5.682

9.  Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

Authors:  Zhi Teng; Shijuan Xu; Qin Lei
Journal:  Oncol Rep       Date:  2019-12-31       Impact factor: 3.906

10.  Expression of Autophagy-Related Factors LC3A and Beclin 1 and Apoptosis-Related Factors Bcl-2 and BAX in Osteoblasts Treated With Sodium Fluoride.

Authors:  Lin Xu; Chaonan Deng; Ying Zhang; Lina Zhao; Yan Linghu; Yanni Yu
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.